TETRAPHASE PHARMACEUTICALS INC Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
TETRAPHASE PHARMACEUTICALS INC reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$12.12 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$12.12M.
- TETRAPHASE PHARMACEUTICALS INC net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$19.49M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month |
|---|---|
| 2020-03-31 | -$12.12M 10-Q · filed 2020-05-07 |
| 2019-03-31 | -$19.49M 10-Q · filed 2020-05-07 |